导师 发表于 2025-3-23 13:20:06

Submitted on: 08 January 2003.
Revised on: 08 February 2003.
Accepted on: 02 March 2003.
Pharmacology Research & Perspectives

formula 发表于 2025-3-23 16:05:23

Submitted on: 16 November 2005.
Revised on: 14 December 2005.
Accepted on: 22 December 2005.
Pharmacology Research & Perspectives

Melanoma 发表于 2025-3-23 19:56:21

http://reply.papertrans.cn/3/245/24421/24421-13.png

对手 发表于 2025-3-23 22:16:26

Submitted on: 23 May 2018.
Revised on: 05 June 2018.
Accepted on: 18 June 2018.
Pharmacology Research & Perspectives

羞辱 发表于 2025-3-24 02:35:16

Submitted on: 26 August 2011.
Revised on: 29 September 2011.
Accepted on: 07 October 2011.
Pharmacology Research & Perspectives

分开 发表于 2025-3-24 08:45:18

http://reply.papertrans.cn/3/245/24421/24421-16.png

无政府主义者 发表于 2025-3-24 12:14:21

Submitted on: 27 September 2003.
Revised on: 01 November 2003.
Accepted on: 14 November 2003.
Pharmacology Research & Perspectives

马赛克 发表于 2025-3-24 17:11:24

Submitted on: 11 November 2018.
Revised on: 30 November 2018.
Accepted on: 10 December 2018.
Pharmacology Research & Perspectives

开始发作 发表于 2025-3-24 21:17:58

http://reply.papertrans.cn/3/245/24421/24421-19.png

欲望 发表于 2025-3-25 00:55:38

http://reply.papertrans.cn/3/245/24421/24421-20.png
页: 1 [2] 3 4
查看完整版本: SCIE期刊Pharmacology Research & Perspectives 2024/2025影响因子:2.931 (PHARMACOL RES PERSPE) (2052-1707). (PHARMACOLOGY & PHAR